Pharmaceutical marketing and the NHS drugs bill are once again in the spotlight with MPs criticising the industry's influence and …
US market research company Manhattan Research has launched a new European service to examine trends in physician's use of technology …
European regulators have approved GlaxoSmithKline's new once-daily corticosteroid nasal spray for allergic rhinitis. Avamys was granted a licence to treat …
AstraZeneca's Crestor will go head-to-head with Pfizer's mega-brand Lipitor in a global trial assessing the two statins in cardiovascular disease. …
Pfizer will partner with German biopharmaceutical company Scil Technology to develop and commercialise a new early-stage biotech treatment for cartilage …
Stakeholders have voiced fresh fears pharma is moving towards advertising prescription medicines to consumers after the European Commission continued in …
The spectacular growth which has made Genentech the world's biggest biotech company is set to slow in 2008, as its …
Patients risk safety by taking biotech medicines that are similar but not the same as the branded drug, MPs have …
Latest results for the mandatory ABPI medical representative exam showed a 75% pass rate, but the numbers sitting the test …
Richard Branson’s Virgin group has launched a new business offshoot which will compete to offer GP services around England.Virgin is …
Cancer Research UK is investing ten million pounds in drug discovery projects at four UK universities. Project leaders at Imperial …
European and Canadian regulators have forged a transatlantic agreement to exchange confidential information about the authorisation and safety of medicines. …
Competitive obtains license rights for breast cancer testCompetitive Technologies has signed a license and commercialization agreement for rights to the …
The pharmaceutical industry has made a major reduction in the number of rodents used in pre-clinical drug testing after an …
Millions of pounds in extra funding is to be given to hospitals in England to appoint a team of nurses …
News that the government plans to cut the NHS medicines bill by 10% has taken UK pharma industry leaders by …
A new head-to-head study sponsored by GSK suggests its drug Seretide reduced the risk of dying compared to rival treatment …
John Lechleiter, Lilly's current president and chief operating officer has been named as the company's next chief executive.Sidney Taurel is …
The first ever product to combine all the drugs HIV patients need in just one daily pill has been approved …